Dr Richard Greville is an ABPI Director with Senior Leadership Team responsibility for Wales and International Affairs.
He was initially appointed to the post of Director of ABPI Cymru Wales in May 2003 after serving an apprenticeship of 15 years in a wide range of roles within the pharmaceutical industry. In 2007 Richard gained additional responsibility as Director of ABPI Northern Ireland and enjoyed the challenges of raising the understanding and profile of the pharmaceutical industry with a variety of stakeholders, including Assembly policy makers and influencers.
On relinquishing responsibility for Northern Ireland in November 2012, Richard has assumed responsibility for International Affairs, representing the interests of both the ABPI and UK. This includes representing ABPI strategically at both the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), identifying, responding and influencing proposals which may impact on ABPI members. He is also the principle conduit for ABPI engagement with UK Trade & Investment (UKTI), World Trade Organization (WTO) and others on international issues such as Intellectual Property and Trade Bi-laterals. He works alongside UK Life Science and the Department for Business, Innovation & Skills (BIS) to support the Office of Life Sciences inward investment strategy.
He is also a member of the Advisory Boards of the National Institute for Social Care and Health Research, Health Informatics Research Unit (HIRU) at Swansea University, Diabetes Diploma at the University of Glamorgan, and the Wales Cancer Bank.